1. Home
  2. TIL vs PTMN Comparison

TIL vs PTMN Comparison

Compare TIL & PTMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • PTMN
  • Stock Information
  • Founded
  • TIL 2018
  • PTMN 2006
  • Country
  • TIL United States
  • PTMN United States
  • Employees
  • TIL N/A
  • PTMN N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • PTMN Finance: Consumer Services
  • Sector
  • TIL Health Care
  • PTMN Finance
  • Exchange
  • TIL Nasdaq
  • PTMN Nasdaq
  • Market Cap
  • TIL 171.7M
  • PTMN 142.6M
  • IPO Year
  • TIL 2021
  • PTMN N/A
  • Fundamental
  • Price
  • TIL $17.21
  • PTMN $14.15
  • Analyst Decision
  • TIL Buy
  • PTMN Hold
  • Analyst Count
  • TIL 5
  • PTMN 1
  • Target Price
  • TIL $114.00
  • PTMN $16.00
  • AVG Volume (30 Days)
  • TIL 85.6K
  • PTMN 54.6K
  • Earning Date
  • TIL 03-04-2025
  • PTMN 03-13-2025
  • Dividend Yield
  • TIL N/A
  • PTMN 14.97%
  • EPS Growth
  • TIL N/A
  • PTMN N/A
  • EPS
  • TIL N/A
  • PTMN N/A
  • Revenue
  • TIL N/A
  • PTMN $62,432,000.00
  • Revenue This Year
  • TIL N/A
  • PTMN $6.34
  • Revenue Next Year
  • TIL N/A
  • PTMN N/A
  • P/E Ratio
  • TIL N/A
  • PTMN N/A
  • Revenue Growth
  • TIL N/A
  • PTMN N/A
  • 52 Week Low
  • TIL $9.62
  • PTMN $14.15
  • 52 Week High
  • TIL $92.00
  • PTMN $20.84
  • Technical
  • Relative Strength Index (RSI)
  • TIL 42.69
  • PTMN 17.80
  • Support Level
  • TIL $17.87
  • PTMN $14.30
  • Resistance Level
  • TIL $19.61
  • PTMN $15.69
  • Average True Range (ATR)
  • TIL 1.68
  • PTMN 0.43
  • MACD
  • TIL -0.06
  • PTMN -0.16
  • Stochastic Oscillator
  • TIL 5.69
  • PTMN 1.83

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About PTMN Portman Ridge Finance Corporation

Portman Ridge Finance Corp Inc is a non-diversified closed-end investment company. The company originates, structures, and invests in secured term loans, bonds or notes, and mezzanine debt primarily in privately-held middle market companies but may also invest in other investments such as loans to publicly traded companies, high-yield bonds, and distressed debt securities. The company's investment objective in the Debt securities portfolio is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt, and selected equity investments in privately-held middle market companies.

Share on Social Networks: